Hunan Hansen Pharmaceutical (002412.SZ)Engelcare tablets have completed drug registration.

date
11/02/2025
avatar
GMT Eight
Hunan Hansen Pharmaceutical (002412.SZ) announced that the company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the chemical drug "Empagliflozin Tablets". This drug is used for the treatment of type 2 diabetes, as well as for adult patients with symptomatic chronic heart failure to reduce the risk of hospitalization due to heart failure.

Contact: contact@gmteight.com